Company Celebrates 10 Years of the Industry’s Leading Guide Extension Catheter with More Than 1 Million Units Sold Worldwide WAYNE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the tenth anniversary of its industry-leading GuideLiner® Catheter. Released in November […]
Other News
THE SAGE GROUP LLC Comments on National Peripheral Artery Disease (PAD) Awareness Month
BEAUFORT, S.C.–(BUSINESS WIRE)–According to THE SAGE GROUP, in 2015 almost 20 million Americans suffered from PAD representing an economic burden of $224-$414 billion. “Almost 20 years ago, we wrote that PAD was underestimated, underdiagnosed and undertreated,” stated Mary L. Yost, President. “Unfortunately, this is still true.” Reflecting on the current […]
Vital Metrix Wins 2019 MedTech Breakthrough Awards Program
RESTON, Va.–(BUSINESS WIRE)–Vital Metrix, Inc. today announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has selected the company as the winner of its “Best Biometric Sensor Solution” award in the 2019 MedTech Breakthrough Awards program. Vital Metrix, Inc. […]
Cardiovascular Systems, Inc. Announces FDA Approval of the Coronary ViperWire Advance® With Flex Tip
U.S. Approval of the First and Only Nitinol Atherectomy Guide Wire Expands Company’s Portfolio of Products Targeting Complex Coronary Disease ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced […]
Journal Of Vascular Access Publishes Positive Clinical Results For Bluegrass Vascular’s Surfacer® System
Additional clinical evidence to be highlighted at upcoming Controversies in Dialysis Access (CiDA) and American Society of Nephrology (ASN) meetings SAN ANTONIO, Sept. 24, 2019 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of positive results associated […]
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare Dedicated Investors Companies to Hold Conference Call on September 24th at 8:30AM EDT WALTHAM, Mass. and NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) — Proteon […]
Catasys Announces $45 Million Debt Financing Commitment from Goldman Sachs to Support Accelerating Growth
LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, has entered into a financing agreement with Goldman Sachs Specialty Lending Group, L.P. (“Goldman Sachs”) involving the placement of Senior Secured Notes due 2024 pursuant to a committed purchase of up to $45 million, comprised […]
Attune Medical Expands IP Portfolio with Issuance of Additional Patent from USPTO and Acquisition of License from Stanford University
CHICAGO–(BUSINESS WIRE)–Chicago-based medical device firm Attune Medical has expanded its pioneering patent portfolio with two major advancements. The USPTO recently issued a broad method patent for Devices and Methods for Controlling Patient Temperature (US Patent number 10,363,162), which is the first patent in the Attune portfolio that specifically claims the […]
Highest Court in Germany Affirms Strength of Abiomed’s Patents
DANVERS, Mass.–(BUSINESS WIRE)–The highest court in Germany, the Federal Court of Justice, recently ruled in favor of Abiomed (NASDAQ: ABMD) in a patent challenge filed by Thoratec in 2015 and validated the strengths of Abiomed’s Impella-related patents. These patents are also the subject of a separate patent infringement action Abiomed […]
Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Patients
Improved Functionality Across Four Valve Sizes and Lowest Delivery Profile on the Market, the Evolut PRO+ TAVR System Launches in U.S. as TAVR Patient Population Grows DUBLIN, Sept. 23, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), a global leader in heart valve therapies, today announced U.S. Food and Drug Administration […]
Recent
Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
Popular
- No commented posts yet